On Mar. 16, Bright Dairy announced a non-public olevonorgestrel and ethinyl estradiol and ferrous bisglycinateffering plan to raise 1.93 billion CNY from no more than 35 specific investoferrous fumarate 210mg tablets indiars. Brighgalfer capsules 305 mg ferrous fumaratet Food, the ferrous bisglycinate benefitscontrolling shareholder of Bright Dairy, intended to subscribe for 51.73% of the additional shares to maintaiferrous fumarate medicinen its proportion.
Latest Milk Source Campaign in China: Bright Dairy’s Farm Investment and Fonterra’s Retreat
